璧辰(上海)医药科技有限公司 ABM THERAPEUTICS SHANGHAI COMPANY LIMITED
{{company.company_channel.channel_name}}
{{company.company_name_local}}
{{company.company_channel.channel_name}}
ABM Therapeutics Receives IND Approval in China for BRAF Inhibitor ABM-1310 2021-11-30 13:00
ABM Therapeutics Announces First Patient Dosed in Phase 1 Clinical Trial of ABM-1310 in the USA 2020-06-22 23:00
1